Elevated post-void residual volume in a geriatric post-hip fracture assessment in women-associated factors and risk of mortality by Nuotio, Maria S. et al.
1ELEVATED POST-VOID RESIDUAL VOLUME IN A GERIATRIC POST-HIP FRACTURE
ASSESSMENT IN WOMEN -ASSOCIATED FACTORS AND RISK OF MORTALITY
Maria Nuotio, MD, PhD
Chief, Department of Geriatric Medicine
Seinäjoki Central Hospital
Seinäjoki, Finland
Tiina Luukkaala, MSc
Biostatistician
Science Center, Pirkanmaa Hospital District, Tampere
School of Health Sciences,
University of Tampere, Finland
Teuvo Tammela, MD, PhD
Professor and Chairman
Department of Surgery
Faculty of Medicine and Life Sciences
University of Tampere and
Tampere University Hospital,
Tampere, Finland
Corresponding author:
Maria Nuotio
Department of Geriatric Medicine
Seinäjoki Central Hospital
Hanneksenrinne 7
60220 SEINÄJOKI
Finland
Phone: +358503536024
E-mail: maria.nuotio@fimnet.fi
Key words: detrusor underactivity, post-void residual, hip fracture, physical functioning, geriatric
assessment
Running title: Residual volume and post-hip fracture assessment
This is the post print version of the article, which has been published in Aging Clinical and Experimental 
Research. 2019, 31(1), 75-83.  
http://dx.doi.org/10.1007/s40520-018-0946-5
2ABSTRACT
Background and Aim:  Multiple factors contribute to elevated post-void residual urine volumes
(PVR) but they may indicate detrusor underactivity (DU), especially in older women. The aim here
was to examine factors associated with and prognostic significance of elevated PVR in a geriatric
post-hip fracture assessment in a female population.
Methods: Consecutive female hip fracture patients (n=409) aged 65 years and older were included.
PVR was measured by bladder scanner. PVR of 160 ml or more was deemed elevated. Age-
adjusted univariate logistic regression analyses were conducted to examine the association of the
domains of the comprehensive geriatric assessment (CGA) with elevated PVR. Cox proportional
hazards model was used to determine the age-adjusted association of an elevated PVR with one-
year mortality.
Results: Of the patients 64 (15.6%) had elevated PVR. Having urinary or faecal incontinence,
difficulties in physical activities of daily living, malnutrition, poor performance on Timed Up and
Go and Elderly Mobility Scale were significantly associated with elevated PVR. Difficulties in
instrumental activities of daily living, renal dysfunction, constipation, polypharmacy, nocturia,
cognitive impairment and depressive mood were not associated with elevated PVR. Elevated PVR
significantly increased the risk of mortality one year post-hip fracture.
Conclusions: Elevated PVR is relatively common in older female hip fracture patients and
associated with physical functioning, malnutrition and risk of mortality.  Even though a causal
relationship cannot be confirmed, the findings may suggest a relationship between DU and physical
frailty. PVR deserves to be included in the CGA of frail older patients including women.
3INTRODUCTION
Urinary dysfunction related to both storage and voiding phases of the micturition cycle is common
among older people. Among storage symptoms, urinary incontinence (UI), particularly urgency
incontinence (UUI), is acknowledged as one of the major geriatric syndromes with considerable
impacts on functional ability, quality of life, prognosis and costs to the social and health care
services of aging societies [1]. Nocturia is also considered a multifactorial symptom entity in its
own right [2]. Voiding symptoms are known to be frequent, especially in older men due to bladder
outlet obstruction (BOO) related to benign prostatic enlargement (BPE) caused by benign prostatic
hyperplasia (BPH). However, voiding symptoms are not BPE or gender specific since older men
without BOO and older women may also report similar symptoms [3,4].
Detrusor underactivity (DU) is a poorly understood geriatric condition which has received relatively
little attention either clinically or in research [5,6]. According to a definition proposed by the
International Continence Society (ICS), DU is characterized as a contraction of reduced strength
and/or duration of the detrusor resulting in prolonged bladder emptying and/or failure to achieve
complete bladder emptying within a normal time span [7]. The prevalence of DU is believed to be
high in frail and institutionalized older individuals and may be accompanied by detrusor
overactivity (DO), leading to a complex condition known as detrusor hyperactivity with impaired
contractility (DHIC) [8].
Elevated post-void residuals (PVRs) in older patients are multifactorial in nature [5,6]. Moreover,
the causative and predisposing factors may differ between men and women. Constipation or
medications causing problems in bladder emptying may underlie the finding in both sexes [9,10].
Elevated PVR may also indicate DU. PVR can be easily measured on portable ultrasound devices
[11]. The method is noninvasive, patient friendly, and yields reliable results. In men, elevated PVRs
may suggest BOO attributed to BPE and the measure cannot be differentiated from elevated PVRs
related to DU. In women, BOO is more uncommon and elevated PVRs may be consequently more
likely to be associated with DU. Lack of estrogen has also been suggested as one possible
mechanism of DU in older women (6).
Hip fractures in older individuals typically affect multimorbid and frail patient population. The aim
of the present study were to examine the prevalence and factors associated with elevated PVRs in a
consecutive series of female patients invited to a comprehensive geriatric assessment (CGA) in an
4outpatient setting 4-6 months after sustaining a hip fracture.  In addition, we aimed to assess the
prognostic significance of an elevated PVR for hip fracture mortality.
MATERIAL AND METHODS
As a part of an established local care pathway, all hip fracture patients aged 65 years and over
suffering their first hip fracture between January 2011 and April 2015, were invited for a CGA at
the geriatric outpatient clinic 4-6 months (median 6 months; Interquartile Range [IQR] 4-6 months)
after the hip fracture. All the hip fracture patients in the area, with a population of some 200 000,
are treated in our hospital.  The process of the outpatient assessment has been described in greater
detail elsewhere [12]. A physiotherapist’s assessment precedes the geriatric assessment.  Patients’
preoperative American Society of Anesthesiologists (ASA) scores [13] were used to assess the
general health status. There are five classes: 1) healthy person, 2) mild systemic disease, 3) severe systemic
disease, 4) severe systemic disease that is a constant threat of life, and 5) a moribund person who is not
expected to survive without the operation.
At the outpatient clinic, standardized and well-known measures were used for different domains for
the CGA [12].  Briefly, cognitive function was measured by the Mini Mental State Examination
(MMSE) [14], depressive mood on the 15-item Geriatric Depression Scale (GDS-15) [15], activities
of daily living on  the Physical Activities of Daily Living Index (PADL) introduced by Katz [16]
and Instrumental Activities of Daily Living (IADL) by Lawton and Brody [17], nutritional status on
the short and long forms of the Mini Nutritional Assessment (MNA-SF and MNA-LF) [18].
Number of regularly taken medications at the time of the fracture was registered and any urinary
and faecal incontinence or constipation were elicited. Based on questions on different types of
urinary incontinence, stress urinary incontinence (SUI) was defined as having urinary leakage
during physical exertion such as coughing or lifting, and UUI as having urinary leakage associated
with an urgency to urinate. Mixed urinary incontinence was defined as a combination of the SUI
and UUI. Nocturia was defined as the number of voids during the night. Renal function was
assessed by calculating the estimated Glomerular Filtration Rate as according to the Cockroft and
Gault formula (eGFR) [19].
In the physiotherapist’s assessment, Timed Up and Go (TUG) [20] was measured both as time and
as categorized by the examining physiotherapist. In addition, mobility was assessed and categorized
on the Elderly Mobility Scale (EMS) [21]. Muscle strength was measured as grip strength in the
stronger hand with Jamar dynamometer. Grip strength less than 16 kg in the stronger hand was
5defined as weakened [22]. The categorization of the variables used in the CGA and
physiotherapist’s assessment appears in Table 2.
There is no exact definition of elevated PVR. In younger adult patients a PVR of 50-100 ml or more
is deemed elevated [6]. In older patient populations a clearly higher PVR is accepted. Definitions of
elevated PVR in the literature vary from 150 ml to 200 ml or more [6]. The PVR limit value used in
clinical decision-making may be even higher, especially in the frail female patient population. It has
been proposed that generally a PVR of more than half of the bladder capacity should lead to
interventions [6].The dependent variable of elevated PVR in the present study was defined as PVR
160 ml or more as measured transabdominally immediately after micturation using a portable
bladder scanner. A limit value of 160 ml was chosen based on calculations on specificity and
sensitivity with an 80% percentile.
The baseline and one-year mobility level were defined in a similar way. It was categorized as 1)
ability walk outdoors unassisted, 2) ability walk indoors unassisted, 3) ability to walk assisted only
or 4) unable to walk. The change in the mobility level between the time of the fracture and one year
thereafter was defined as declined vs. same or improved mobility level. The data on mobility level
were collected by a geriatric nurse trained for the purpose.
Dates of death for the mortality analysis were extracted from the electronic patient files. There were
no losses to mortality follow-up. The study was approved by the Ethics Committee of Hospital
District of Southern Ostrobothnia. All the patients or their representatives gave informed consent.
A dropout analysis was carried out comparing the baseline characteristics among the attendees, non-
attendees, and the patients who had died before follow-up (Table 1). Differences between groups
were calculated by Fisher’s exact test in the cases of categorical variables. Linear associations of
continuous variables were evaluated by Spearman’s correlation coefficients (rho). A p-value of <0.05
was considered statistically significant.
In order to examine the association of each domain of the CGA with an elevated PVR, age-adjusted
univariate logistic regression models were used introducing each variable separately into the model
with odds ratios (OR) and 95% confidence intervals (CI). Age-adjusted association of an elevated
PVR with one-year mortality was assessed with Cox regression hazards models showing results by
hazard ratios (HR) with 95% confidence intervals (CI). In addition, an age- and baseline mobility
level -adjusted multinomial logistic regression analysis with ORs and CIs was constructed to examine
the association of elevated PVR with decline in mobility vs. same on improved mobility level and
6mortality  one  year  post-hip  fracture.  All  statistical  analyses  were  performed  using  IBM  SPSS
Statistics version 23 (IBM SPSS Statistics, IBM Corporation, Chicago, IL).
RESULTS
Of the 663 patients 17% had died before the follow-up. Of the survivors, 75% (409) attended the
outpatient assessment. Compared to the attendees, the non-attendees and the deceased patients were
more likely to have higher ASA scores, greater number of regularly taken medications, poorer
nutritional status according to the MNA, and they were more likely to need assistance in walking
and to be living in assisted living accommodation or in an institution at baseline. (Table 1)
Of the 409 patients 64 (15.6%) had an elevated PVR as measured by the bladder scanner. The
median PVR was 29 ml (IQR 5-93ml, range 0-855 ml).
The distribution of the domains of the CGA and the tests included in the physiotherapist’s
assessment according the dichotomized PVR variable are shown in Table 2. The results of the age-
adjusted univariate logistic regression analyses for the associations of each the independent variable
with an elevated PVR are also shown in Table 2. Of the CGA domains, having any or UUI, faecal
incontinence, difficulties in PADLs and malnutrition measured either by the short or long form of
the MNA were significantly associated with elevated PVR. Of the tests conducted by the
physiotherapist, both longer time or markedly abnormal score on the TUG and the poorest result on
the EMS were significantly associated with elevated PVR. Renal dysfunction, number of
medications, nocturia, constipation, cognitive impairment, depressive mood, difficulties in IADLs
and weakened grip strength were not significantly associated with elevated PVR. Of the patients 13
(20.3% of those with elevated PVR) had a PVR greater than 400 ml and of these 10 (76.9%)
reported urinary incontinence.
Increased PVR was linearly associated with weakened grip strength among women aged 80-89
years (Spearman’s rho=-0.149, p=0.039, n=193), but not among women aged 65-79 and over 90
years (rho=-0.051, p=0.627, n=94 and rho=0.054, 9=0.711, n=50 respectively).
Of the patients with elevated PVR, compared to the patients with non-elevated PVR, 12.5% (n=9)
vs. 2.6% (n=8) (p=0.002) had died within one year of the hip fracture. In the age-adjusted Cox
proportional hazards model, patients with elevated PVR had an increased risk of death within one
year of the hip fracture (HR 4.35; 95% CI 1.57-12.03) (Figure 1).
7In the additional multinomial age-and baseline mobility level –adjusted regression model, elevated
PVR was associated with both declined mobility (n=131) (OR 1.95;95%CI 1.05-3.61) and mortality
(OR 4.50;95%CI 1.50-13.5) one year post-hip fracture.
DISCUSSION
The essential finding of this study was the association of elevated PVR in a substantial number of
consecutive older female hip fracture patients with functional and mobility disability, both urinary
and faecal incontinence, and malnutrition. The association of elevated PVR with mortality one year
post-hip fracture corroborates an earlier observation of the predictive value of postoperative urinary
retention in older female hip fracture patients [23].
Elevated PVR was not uncommon in our patient population. Very few studies have addressed the
prevalence of elevated PVRs or urinary retention in older female populations. Most studies on
urinary retention in hip fracture patients have concentrated on the immediate peri- and postoperative
phase of hip fracture care where prevalences have been higher and volumes of urinary retention
have been greater than those reported in the present study [23,24]. One study reported a prevalence
of 20% in the recovery phase of older female hip fracture patients, a figure relatively close to that
reported in our study [23]. Given that the non-attendees were more incapacitated [12]), the result of
our study on the prevalence of elevated PVRs may include a selection bias.  Due to the association
of elevated PVR with disability, the bias is more likely to involve underreporting than
overreporting.
We found a strong association between elevated PVR and the tests conducted by the physiotherapist
on patients’ mobility. Overall poorer scores on TUG and EMS predicted elevated PVR. An
association between elevated PVR and impaired mobility has been reported in older female
hospitalized patients [25]. Moreover, older female hip fracture patients without perioperative
urinary retention (POUR) showed significantly better motor and total Functional Independence
Measure (FIM) gains on discharge compared with females with POUR [24]. Even though no
association between weakened grip strength and elevated PVR was observed in the cohort as a
whole, our tests revealed a weak, but statistically significant linear association between elevated
PVR and weakened grip strength in the age group of 80-89 years. Interestingly, an association was
observed between elevated PVR and declined mobility one year post-hip fracture. It is worth noting
that, in the present study, an association emerged between elevated PVR and indicators of physical
functioning but not between those of psychocognitive domains.
8There was an association between elevated PVR and reporting any urinary incontinence.
Difficulties in bladder emptying may lead in the most severe cases to overdistention of the detrusor
resulting in overflow urinary incontinence [10]. In the present study, the PVR exceeded the usual
bladder capacity of 400 ml in one fifth of the patients with elevated PVR and a significant
proportion of these patients reported urinary incontinence eventually suggesting an overflow
situation.
An association was observed of elevated PVR with UUI but not with SUI. A similar finding has
been reported in a study on risk factors for elevated PVR in women with urgency symptoms [26].
The finding may be explained by the close relationship between DO and DU [27] and may imply
DHIC, a condition originally described by Resnick and Yalla as early as in 1987 [8]. Up to two
thirds of frail older patients living in nursing homes have been estimated to suffer from DHIC. In a
more recent study, history of back surgery or injury and pelvic surgery were found to be associated
with difficulties in bladder emptying in older women with symptoms of an overactive bladder
(OAB) [28]. Elevated PVR was not significantly associated with nocturia, implying that its etiology
was beyond the urinary bladder [29].
We demonstrated an association between elevated PVR and faecal incontinence, which again
emphasizes the association between DU and disability. Constipation may be a contributory factor
for both difficulties in bladder emptying and incontinence, either urinary and/or faecal [9].  In an
earlier study, an association was found between elevated PVR and constipation in older female
inpatients [25]. We found no such association.
The strengths of our study include significant series of patients enabling a sample size big enough to
ensure sufficient statistical power and use of well-known and standardized measures in the CGA.
The measurement of PVR was conducted in a similar way in all participants. Moreover, the
mortality data were complete. There are also a number of limitations to the study.  First of all, the
sample represents a selected sample of hip fracture patients, which may have affected the reliability
of the findings. According to our dropout analysis, a significant proportion of the most severely
disabled patients had either died before follow-up or were among the non-attendees. Second,
comorbidities were not recorded in detail and except for ASA scores, no indices for comorbidities
were used. For example, diabetes and degenerative back diseases are known to impair the
contractility of the urinary bladder and urinary dysfunction may also occur in neurological disorders
common in older people [10]. In addition, even though BOO is known to be more frequent in older
men than in women, BOO in women may sometimes occur in cases of pelvic prolapses. These were
not examined in our patient population. Third, we only examined the association of total number of
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the urinary bladder, especially those with anticholinergic properties [10]. Fourth, the PVRs were not
assessed at the time of the fracture and thus changes in the PVRs between the time of the acute hip
fracture care and follow-up could not be examined. Also, we focused on examining the female
population. This was mainly done because we were unable to exclude the possible effect of BOO
related to BPE in male patients. Nevertheless, we did conduct analyses for the male population
(n=145) but only higher age and moderate renal dysfunction as measured by the estimated GFR
were significantly associated with elevated PVR. Quite expectedly, the prevalence of an elevated
PVR of 27.6% in men was higher than that in women. Interestingly, unlike in women, elevated
PVR did not predict mortality in men. This concurs with a study by Adunsky and colleagues [24].
The differences in the findings between the genders imply different etiological pathways associated with
elevated PVR.  Finally, due to small number of cases, the confidence intervals in the mortality analyses were
relatively wide and therefore the results should be interpreted with some caution.
Given the association between urinary incontinence, the UUI in particular, and elevated PVR, the possibility
of DU should be taken into account when planning treatments for UI in frail older patients. Patients with DU
may be at risk of further urinary retention when taking UI medications, especially antimuscarinics. These
medications are known to carry a risk of a number of other harmful effects in the frail patient population
[10]. Mirabegron, a beta3 adrenoreceptor agonist, is a novel UUI medication lacking the harmful effects
associated with antimuscarinics and may less likely increase the PVRs [30].  As urinary retention may
exacerbate renal dysfunction and increase the risk of urinary tract infections, urinary drainage, ideally by
means of intermittent urinary catheterization should be carried out in cases of extremely large PVRs
approaching or exceeding the normal bladder capacity. Moreover, the likelihood of overflow urinary
incontinence has to be kept in mind.  When BOO is suspected, either in women or in men, a gynecologist or
a urologist need to be consulted.
CONCLUSIONS
Elevated PVR is relatively common and associated with physical functioning, malnutrition and risk of
mortality in older female hip fracture patients. Even though a causal relationship cannot be confirmed, the
observations may suggest a connection between DU and physical frailty and highlight the prognostic
significance and the syndromic nature of DU. Clinically it would be appropriate to include a PVR
measurement in the CGA at least in the frail older patients with disabilities, including women. Further
studies are needed to investigate the effect of different groups of medications on elevated PVR and to
examine the role of frailty and sarcopenia in the development of DU in the older population.
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FIGURE CAPTION
Fig1. Age-adjusted 1-year mortality according to the post-void residual volume by cut-off
value 160 ml among women (N=409).
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Table 1. Dropout analysis of the study population (N=663).
Baseline variable Attendees
N=409
Non-Attendees
N=140
Deceased
N=114
n (%) n (%) n (%) p
Age <0.001
65-79 112 (27) 29 (21) 13 (11)
80-89 233 (57) 71 (51) 55 (48)
≥90 64 (16) 40 (29) 46 (40)
ASA  <0.001
1-3 337 (82) 105 (75) 61 (54)
4-5 69 (17) 34 (24) 49 (43)
Not known 3 (1) 1 (1) 4 (4)
Number of regularly taken medications  <0.001
< 4 87 (21) 25 (18) 4 (3)
4-10 254 (62) 84 (60) 72 (64)
> 10 68 (17) 31 (22) 37 (33)
Not known 0 (0) 0 (0) 1 (<1)
Diagnosis of memory disorder 0.097
No 297 (73) 97 (69) 77 (68)
Yes 111 (27) 43 (31) 34 (30)
Not known 1 (<1) 0 (0) 3 (3)
Mobility before fracture <0.001
Outdoors unassisted 246 (60) 51 (36) 25 (22)
Outdoors assisted 148 (36) 65 (46) 72 (63)
Indoors assisted 9 (2) 20 (14) 10 (9)
Unable to walk 5 (1) 3 (2) 2 (2)
Not known 1 (<1) 1 (1) 5 (4)
Living before fracture  <0.001
Home without organized home care 190 (47) 44 (31) 24 (21)
Home with organized home care 131 (32) 39 (28) 24 (21)
Assisted living accomodation 33 (8) 22 (16) 24 (21)
Institutionalized 55 (13) 35 (25) 39 (34)
Not known 0 (0) 0 (0) 3 (3)
eGFR  <0.001
Mild dysfunction, (≥ 60) 136 (33) 31 (22) 16 (14)
Moderate dysfunction (30-59) 185 (45) 65 (46) 54 (47)
Severe dysfunction(<30) 32 (8) 13 (9) 28 (25)
Not known 56 (14) 31 (22) 16 (14)
MNA-SF <0.001
Normal 240 (59) 54 (39) 22 (19)
At risk of malnutrition 147 (36) 73 (52) 71 (62)
Malnourished 20 (5) 12 (9) 14 (12)
Not known 2 (1) 1 (1) 7 (6)
MNA-LF  <0.001
Normal 150 (37) 27 (19) 9 (8)
At risk of malnutrition 165 (40) 67 (48) 65 (57)
Malnourished 11 (3) 10 (7) 13 (11)
Not known 83 (20) 36 (26) 27 (24)
Differences between groups were tested by Pearson chi-square test or Fisher’s exact test.
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Table 2.  Post-void residual volume ≥160 ml at outpatient assessment among women (N=409).
Women (N=409)
≥160 ml
(n=64)
Age-adjusted
N n (%) p OR (95% CI)
Baseline
Age 409 64 (16) 1.03 (0.98-1.07)
Age 0.650
65-79 112 15 (13) 1.00
80-89 233 40 (17) 1.34 (0.71-2.55)
≥90 64 9 (14) 1.06 (0.43-2.58)
Number of regularly taken medications 0.265
< 4 87 9 (10) 1.00
4-10 254 42 (17) 1.67 (0.78-3.60)
> 10 68 13 (19) 2.02 (0.81-5.07)
eGFR 0.546
Mild dysfunction, (≥ 60) 103 16 (16) 1.00
Moderate dysfunction (30-59) 264 44 (17) 0.85 (0.43-1.69)
Severe dysfunction(<30) 37 3 (8) 0.31 (0.08-1.26)
Not known 5 1 (20) 1.07 (0.11-10.6)
Urinary incontinence 0.028
No 167 17 (10) 1.00
Yes 233 46 (20) 2.09 (1.14-3.82)
Not known 9 1 (11) 1.08 (0.13-9.21)
Type of urinary incontinence 0.030
None 216 25 (12) 1.00
Stress 42 5 (12) 1.02 (0.37-2.84)
Urgency 82 20 (24) 2.43 (1.26-4.69)
Mixed 69 14 (20) 1.93 (0.94-3.97)
Nocturia 0.303
No (0-1 times per night) 49 4 (8) 1.00
Yes (at least 2 times per night) 307 52 (17) 2.20 (0.75-6.40)
Not known 53 8 (15) 1.83 (0.51-6.58)
Fecal incontinence 0.003
No 348 47 (14) 1.00
Yes 53 17 (32) 3.01 (1.56-5.80)
Not known 8 0 (0) -
Constipation 0.210
No 188 24 (13) 1.00
Yes 216 40 (19) 1.47 (0.84-2.57)
Not known 5 0 (0) -
MMSE 0.025
24-30 145 16 (11) 1.00
<24 247 42 (17) 1.55 (0.81-2.95)
Not known 17 6 (35) 4.12 (1.32-12.9)
GDS-15 0.141
0-6 317 51 (16) 1.00
6-15 70 7 (10) 0.55 (0.23-1.26)
Not known 22 6 (27) 1.82 (0.67-4.91)
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PADL 0.005
No difficulties (6) 130 10 (8) 1.00
Difficulties (0-5) 273 53 (19) 2.81 (1.34-5.87)
Not known 6 1 (17) 2.36 (0.25-22.3)
IADL 0.277
No difficulties (8) 63 6 (10) 1.00
Difficulties (0-7) 340 57 (17) 1.72 (0.68-4.34)
Not known 6 1 (17) 1.75 (0.17-17.7)
TUG time 345 44 (13) 1.02 (1.004-1.03)
TUG <0.001
Normal (1-2) 138 12 (9) 1.00
Moderately abnormal (3-4) 171 23 (14) 1.58 (0.75-3.35)
Markedly abnormal (5) 26 7 (27) 3.76 (1.30-10.8)
Not known 74 22 (30) 4.27 (1.93-9.44)
Grip strength in stronger hand 0.151
Normal 89 17 (19) 1.00
<16 kg 248 32 (13) 0.54 (0.28-1.06)
Not known 72 15 (21) 0.97 (0.44-2.15)
EMS <0.001
14-20 256 28 (11) 1.00
6-13 87 16 (18) 1.86 (0.94-3.67)
0-5 34 13 (38) 5.12 (2.29-11.4)
Not known 22 7 (32) 3.86 (1.44-10.4)
MNA-SF 0.041
Normal 159 18 (11) 1.00
At risk of malnutrition 192 31 (16) 1.43 (0.76-2.70)
Malnourished 53 13 (25) 2.44 (1.09-5.44)
Not known 5 2 (40) 4.76 (0.74-30.8)
MNA-LF 0.034
Normal 128 18 (14) 1.00
At risk of malnutrition 184 23 (13) 0.83 (0.42-1.62)
Malnourished 34 11 (32) 2.71 (1.12-6.59)
Not known 63 12 (19) 1.39 (0.62-3.12)
Differences between groups (p) were analyzed by Fisher’s exact test. In logistic regression models variables were
entered simultaneously into the model. Results were shown by odds ratios (OR) with 95 % confidence intervals (CI).
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